Stay updated on Cladribine, Idarubicin & Cytarabine for AML Clinical Trial
Sign up to get notified when there's something new on the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page.

Latest updates to the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page
- Check4 days agoChange DetectedA new revision entry labeled v3.6.2 was added to the study record history, and the previous v3.6.0 entry was removed, reflecting an update to the page's revision list.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedLatest history entry adds UI navigation items (Check who can join, Find Contact Information, Study Status) and logs a new revision (v3.6.0) on 2026-06-12. An earlier revision note (2025-12-17, Revision: v3.5.5) was removed from the history.SummaryDifference1%

- Check25 days agoChange DetectedA new revision entry v3.5.5 was added to the record history, and the previous revision v3.5.4 was removed from the list. This updates the study's revision timeline but does not alter study data or descriptions.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 in the Study Record History. This indicates a new version of the record history, primarily reflecting administrative updates rather than changes to the study details.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page footer’s revision identifier is updated from v3.5.2 to v3.5.3, reflecting a site release/version change rather than a modification to the clinical trial record.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.1%

Stay in the know with updates to Cladribine, Idarubicin & Cytarabine for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cladribine, Idarubicin & Cytarabine for AML Clinical Trial page.